Edgewise Therapeutics Inc
EWTX22.670USD
+0.420+1.89%
Close 11/21, 16:00（ET）Quotes delayed by 15 min
2.40BMarket Cap
LossP/E TTM
Edgewise Therapeutics Inc Earnings Date
Period
FY2024 Earnings Date
Revenue(YoY)
--
--
EPS(YoY)
-1.45
7.88%
Analyst Rating
BUY
2025-11-21
Financial Indicators
EPS
Revenue
Net Profit
Net Margin
Gross Margin
Debt to assets ratio
ROE
ROA
Relevant data have not been disclosed by the company yet.
Income Statement
Revenue
Operating profit
Net Profit
Relevant data have not been disclosed by the company yet.
Balance Sheet
Current assets
Total current liabilities
Total assets
Total liabilities
Total equity
Relevant data have not been disclosed by the company yet.
Cash Flow Statement
Net operating income
Net investment
Net financing
Relevant data have not been disclosed by the company yet.
FAQs
What is the total revenue of Edgewise Therapeutics Inc?
According to Edgewise Therapeutics Inc's FY2024 earnings report, its total revenue reached --, with a year-on-year change of --.
What is the Earnings Per Share (EPS) of Edgewise Therapeutics Inc?
According to Edgewise Therapeutics Inc's FY2024 earnings report, its Earnings Per Share (EPS) was -1.448, with a year-on-year change of 7.88%.
What is the net income of Edgewise Therapeutics Inc?
According to Edgewise Therapeutics Inc's FY2024 earnings report, its net income was -133.81M, with a year-on-year change of -33.60%.
What is the net margin of Edgewise Therapeutics Inc?
According to Edgewise Therapeutics Inc's FY2024 earnings report, its net profit margin was --, with a year-on-year change of --.
What is the gross margin of Edgewise Therapeutics Inc?
According to Edgewise Therapeutics Inc's FY2024 earnings report, its gross margin was --, with a year-on-year change of --.
What is the debt-to-asset ratio of Edgewise Therapeutics Inc?
According to Edgewise Therapeutics Inc's FY2024 earnings report, its debt-to-asset ratio was --, with a year-on-year change of --.
What is the Return on Equity (ROE) of Edgewise Therapeutics Inc?
According to Edgewise Therapeutics Inc's FY2024 earnings report, its Return on Equity (ROE) was -34.40%, with a year-on-year change of -14.28%.
What is the Return on Assets (ROA) of Edgewise Therapeutics Inc?
According to Edgewise Therapeutics Inc's FY2024 earnings report, its Return on Assets (ROA) was -32.37%, with a year-on-year change of -14.25%.
What is the operating profit of Edgewise Therapeutics Inc?
According to Edgewise Therapeutics Inc's FY2024 earnings report, its operating profit was -158.83M, with a year-on-year change of -38.89%.
What are the current assets of Edgewise Therapeutics Inc?
According to Edgewise Therapeutics Inc's FY2024 earnings report, its current assets were 475.48M, with a year-on-year change of 45.41%.
What are the total assets of Edgewise Therapeutics Inc?
According to Edgewise Therapeutics Inc's FY2024 earnings report, its total assets of Edgewise Therapeutics Inc were 486.82M, with a year-on-year change of 43.17%.
What are the total liabilities of Edgewise Therapeutics Inc?
According to Edgewise Therapeutics Inc's FY2024 earnings report, its total liabilities of Edgewise Therapeutics Inc were 27.60M, with a year-on-year change of 30.16%.
What is the total equity of Edgewise Therapeutics Inc?
According to Edgewise Therapeutics Inc's FY2024 earnings report, its total equity of Edgewise Therapeutics Inc was 459.22M, with a year-on-year change of 44.03%.
What is the net operating income of Edgewise Therapeutics Inc?
According to Edgewise Therapeutics Inc's FY2024 earnings report, its net operating income of Edgewise Therapeutics Inc was -133.81M, with a year-on-year change of -33.60%.
What is the net investment of Edgewise Therapeutics Inc?
According to Edgewise Therapeutics Inc's FY2024 earnings report, its net investment of Edgewise Therapeutics Inc was -184.66M, with a year-on-year change of -279.48%.
What is the net financing of Edgewise Therapeutics Inc?
According to Edgewise Therapeutics Inc's FY2024 earnings report, its net financing of Edgewise Therapeutics Inc was 249.25M, with a year-on-year change of 368.82%.
